These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 9784935)

  • 21. [Pharmacokinetic, bacteriological and clinical evaluation of biapenem (L-627) in the pediatric field].
    Iwai N; Nakamura H; Taneda Y
    Jpn J Antibiot; 1994 Dec; 47(12):1706-22. PubMed ID: 7877252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy.
    Li X; Sun S; Wang Q; Zhao Z
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):45-53. PubMed ID: 28616823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)].
    Van Bambeke F; Tulkens PM
    Med Mal Infect; 2009; 39(7-8):483-92. PubMed ID: 19500928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyogenic bacterial infections of the CNS.
    Overturf GD
    Neurol Clin; 1986 Feb; 4(1):69-90. PubMed ID: 3724740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid.
    Täuber MG; Sande MA
    Scand J Infect Dis Suppl; 1990; 74():173-8. PubMed ID: 2097706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)].
    Modai J
    Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.
    Nau R; Prange HW; Menck S; Kolenda H; Visser K; Seydel JK
    J Antimicrob Chemother; 1992 Jun; 29(6):719-24. PubMed ID: 1506352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections.
    Peng QL; Tao SH; Yu N; Zhou XZ; Peng YZ; Fu N
    Int J Neurosci; 2017 Jan; 127(1):1-9. PubMed ID: 26710878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
    Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
    J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid.
    Skopnik H; Heimann G
    Pediatr Pharmacol (New York); 1983; 3(3-4):313-20. PubMed ID: 6330656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of purulent meningitis in childhood].
    Guggenbichler JP; Allerberger F; Dietze O; Klima G
    Padiatr Padol; 1989; 24(1):3-19. PubMed ID: 2654817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic prophylaxis in cerebrospinal fluid shunting: reassessment of Cefotiam penetration into human CSF.
    Knoop M; Schütze M; Piek J; Drewelow B; Mundkowski R
    Zentralbl Neurochir; 2007 Feb; 68(1):14-8. PubMed ID: 17487803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
    Di Paolo A; Gori G; Tascini C; Danesi R; Del Tacca M
    Clin Pharmacokinet; 2013 Jul; 52(7):511-42. PubMed ID: 23605634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
    Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
    Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
    Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
    Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
    Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
    Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial and temporal variation of routine parameters: pitfalls in the cerebrospinal fluid analysis in central nervous system infections.
    Djukic M; Lange P; Erbguth F; Nau R
    J Neuroinflammation; 2022 Jul; 19(1):174. PubMed ID: 35794632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.